SHANNON HALL: Open Payments
NPI 1255536447 · STATESBORO, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$438 in 18 payments from 8 companies in 2025. Trend: 2023 $415 · 2024 $505 · 2025 $438
Food & beverage: $393Education: $45
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 5 | $160 |
| Astellas Pharma US Inc | 3 | $80 |
| Biogen, Inc. | 3 | $54 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $47 |
| Lilly USA, LLC | 1 | $45 |
| OptumHealth Care Solutions, LLC | 1 | $21 |
| Abbott Laboratories | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
Products named: MYFEMBREE, Veozah, Mirena, ZURZUVAE, GEMTESA, VIVIFY HEALTH CARE TEAM PORTAL 001, VUMERITY, FREESTYLE LIBRE 3.
Industry payments across GA — which companies pay providers there.
